Neurotoxicity of methamphetamine and 3,4-methylenedioxymethamphetamine

Life Sciences

Volumn 97, Issue 1, 2014, Pages 37-44

  Halpin, Laura E ^a   Collins, Stuart A ^a   Yamamoto, Bryan K ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

3 4 Methylenedioxymethamphetamine; Excitotoxicity; Methamphetamine; Neurotoxicity; Oxidative stress; Psychosis

Indexed keywords

3-4-METHYLENEDIOXYMETHAMPHETAMINE; EXCITOTOXICITY; METHAMPHETAMINE; NEUROTOXICITY; OXIDATIVE STRESS; PSYCHOSIS;

ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; DOPAMINE; HALLUCINOGENS; HUMANS; METHAMPHETAMINE; MITOCHONDRIA; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NERVE ENDINGS; NEUROTOXICITY SYNDROMES; OXIDATIVE STRESS; SEROTONIN;

EID: 84894049198     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2013.07.014     Document Type: Review

References (168)

1. L. Afanador, I. Mexhitaj, C. Diaz, D. Ordonez, L. Baker, and J.A. Angulo The role of the neuropeptide somatostatin on methamphetamine and glutamate-induced neurotoxicity in the striatum of mice Brain Res 1510 2013 38 47
2. M. Ago, K. Ago, K. Hara, S. Kashimura, and M. Ogata Toxicological and histopathological analysis of a patient who died nine days after a single intravenous dose of methamphetamine: a case report Leg Med (Tokyo) 8 2006 235 239 (Pubitemid 44108697)
3. J.H. Anneken, and G.A. Gudelsky MDMA produces a delayed and sustained increase in the extracellular concentration of glutamate in the rat hippocampus Neuropharmacology 63 2012 1022 1027
4. J.H. Anneken, J.I. Cunningham, S.A. Collins, B.K. Yamamoto, and G.A. Gudelsky MDMA increases glutamate release and reduces parvalbumin-positive GABAergic cells in the dorsal hippocampus of the rat: role of cyclooxygenase J Neuroimmune Pharmacol 8 2013 58 65
5. S. Arai, K. Takuma, H. Mizoguchi, D. Ibi, T. Nagai, and K. Takahashi et al. Involvement of pallidotegmental neurons in methamphetamine- and MK-801-induced impairment of prepulse inhibition of the acoustic startle reflex in mice: reversal by GABAB receptor agonist baclofen Neuropsychopharmacology 33 2008 3164 3175
6. G. Battaglia, S.Y. Yeh, E. O'Hearn, M.E. Molliver, M.J. Kuhar, and E.B. De Souza 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites J Pharmacol Exp Ther 242 1987 911 916 (Pubitemid 17156531)
7. M.H. Baumann, M.A. Ayestas Jr., J.S. Partilla, J.R. Sink, A.T. Shulgin, and P.F. Daley et al. The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue Neuropsychopharmacology 37 2012 1192 1203
8. R. Ben-Abraham, O. Szold, V. Rudick, and A.A. Weinbroum 'Ecstasy' intoxication: life-threatening manifestations and resuscitative measures in the intensive care setting Eur J Emerg Med 10 2003 309 313
9. J.M. Brown, E.L. Riddle, V. Sandoval, R.K. Weston, J.E. Hanson, and M.J. Crosby et al. A single methamphetamine administration rapidly decreases vesicular dopamine uptake J Pharmacol Exp Ther 302 2002 497 501 (Pubitemid 34787211)
10. J.M. Brown, M.S. Quinton, and B.K. Yamamoto Methamphetamine-Induced inhibition of mitochondrial complex II: roles of glutamate and peroxynitrite J. Neurochemistry 95 2005 429 436 (Pubitemid 41457511)
11. V. Bruno, U. Scapagnini, and P.L. Canonico Excitatory amino acids and neurotoxicity Funct Neurol 8 1993 279 292 (Pubitemid 23356312)
12. K.B. Burrows, G. Gudelsky, and B.K. Yamamoto Rapid and transient inhibition of mitochondrial function following methamphetamine or 3,4-methylenedioxymethamphetamine administration Eur J Pharmacol 398 2000 11 18 (Pubitemid 30336672)
13. J.L. Cadet, S. Jayanthi, and X. Deng Methamphetamine-induced neuronal apoptosis involves the activation of multiple death pathways. Review Neurotox Res 8 2005 199 206
14. R.C. Callaghan, J.K. Cunningham, G. Sajeev, and S.J. Kish Incidence of Parkinson's disease among hospital patients with methamphetamine-use disorders Mov Disord 25 2010 2333 2339
15. K.N. Cameron, R. Kolanos, E. Solis Jr., R.A. Glennon, and L.J. De Felice Bath salts components mephedrone and methylenedioxypyrovalerone (MDPV) act synergistically at the human dopamine transporter Br J Pharmacol 168 2013 1750 1757
16. J.P. Capela, E. Fernandes, F. Remiao, M.L. Bastos, A. Meisel, and F. Carvalho Ecstasy induces apoptosis via 5-HT(2A)-receptor stimulation in cortical neurons Neurotoxicology 28 2007 868 875 (Pubitemid 47064474)
17. P. Chan, D.A. Di Monte, J.J. Luo, L.E. DeLanney, I. Irwin, and J.W. Langston Rapid ATP loss caused by methamphetamine in the mouse striatum: relationship between energy impairment and dopaminergic neurotoxicity J Neurochem 62 1994 2484 2487 (Pubitemid 24179535)
18. J.P. Chen, W. Paredes, J. Li, D. Smith, J. Lowinson, and E.L. Gardner Delta 9-tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis Psychopharmacology 102 1990 156 162 (Pubitemid 20264653)
19. M. Cherner, C. Bousman, I. Everall, D. Barron, S. Letendre, and F. Vaida et al. Cytochrome P450-2D6 extensive metabolizers are more vulnerable to methamphetamine-associated neurocognitive impairment: preliminary findings J Int Neuropsychol Soc 16 2010 890 901
20. C.Y. Chung, H. Seo, K.C. Sonntag, A. Brooks, L. Lin, and O. Isacson Cell type-specific gene expression of midbrain dopaminergic neurons reveals molecules involved in their vulnerability and protection Hum Mol Genet 14 2005 1709 1725 (Pubitemid 41418045)
21. L. Clark, T.W. Robbins, K.D. Ersche, and B.J. Sahakian Reflection impulsivity in current and former substance users Biol Psychiatry 60 2006 515 522 (Pubitemid 44292153)
22. M.I. Colado, R. Granados, E. O'Shea, B. Esteban, and A.R. Green Role of hyperthermia in the protective action of clomethiazole against MDMA ('ecstasy')-induced neurodegeneration, comparison with the novel NMDA channel blocker AR-R15896AR Br J Pharmacol 124 1998 479 484 (Pubitemid 28254503)
23. D.L. Commins, G. Vosmer, R.M. Virus, W.L. Woolverton, C.R. Schuster, and L.S. Seiden Biochemical and histological evidence that methylenedioxymethamphetamine (MDMA) is toxic to neurons in the rat brain J Pharmacol Exp Ther 241 1987 338 345 (Pubitemid 17119380)
24. H.V. Curran, and R.A. Travill Mood and cognitive effects of +/- 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy'): week-end 'high' followed by mid-week low Addiction 92 1997 821 831 (Pubitemid 27326235)
25. A.S. Darvesh, and G.A. Gudelsky Evidence for a role of energy dysregulation in the MDMA-induced depletion of brain 5-HT Brain Res 1056 2005 168 175 (Pubitemid 41557704)
26. A.S. Darvesh, M. Shankaran, and G.A. Gudelsky 3,4- Methylenedioxymethamphetamine produces glycogenolysis and increases the extracellular concentration of glucose in the rat brain J Pharmacol Exp Ther 301 2002 138 144 (Pubitemid 34250289)
27. A.S. Darvesh, B.K. Yamamoto, and G.A. Gudelsky Evidence for the involvement of nitric oxide in 3,4-methylenedioxymethamphetamine-induced serotonin depletion in the rat brain J Pharmacol Exp Ther 312 2005 694 701 (Pubitemid 40189568)
28. J. Do, and S. Schenk Self-administered MDMA produces dose- and time-dependent serotonin deficits in the rat brain Addict Biol 18 2013 441 447
29. A.J. Ellis, J.A. Wendon, B. Portmann, and R. Williams Acute liver damage and ecstasy ingestion Gut 38 1996 454 458 (Pubitemid 26074327)
30. E. Escubedo, L. Guitart, F.X. Sureda, A. Jimenez, D. Pubill, and M. Pallas et al. Microgliosis and down-regulation of adenosine transporter induced by methamphetamine in rats Brain Res 814 1998 120 126 (Pubitemid 29023417)
31. D.J. Eyerman, and B.K. Yamamoto A rapid oxidation and persistent decrease in the vesicular monoamine transporter 2 after methamphetamine J Neurochem 103 2007 1219 1227 (Pubitemid 47568738)
32. V. Felipo, and R.F. Butterworth Mitochondrial dysfunction in acute hyperammonemia Neurochem Int 40 2002 487 491 (Pubitemid 34159149)
33. V. Felipo, and R.F. Butterworth Neurobiology of ammonia Prog Neurobiol 67 2002 259 279 (Pubitemid 35229984)
34. J. Fernandez-Ruiz, M. Hernandez, and J.A. Ramos Cannabinoid-dopamine interaction in the pathophysiology and treatment of CNS disorders CNS Neurosci Ther 16 2010 e72 e91
35. K.T. Finnegan, J.J. Skratt, I. Irwin, and J.W. Langston The N-methyl-d-aspartate (NMDA) receptor antagonist, dextrorphan, prevents the neurotoxic effects of 3,4-methylenedioxymethamphetamine (MDMA) in rats Neurosci Lett 105 1989 300 306 (Pubitemid 19258892)
36. E. Fitzpatrick, K. Ashkan, B.A. Wallace, A.L. Benabid, and J. Mitrofanis Differential survival patterns among midbrain dopaminergic cells of MPTP-treated monkeys and 6OHDA-lesioned rats Anat Embryol (Berl) 210 2005 101 123 (Pubitemid 41483250)
37. M. Flaum, and S.K. Schultz When does amphetamine-induced psychosis become schizophrenia? Am J Psychiatry 153 1996 812 815 (Pubitemid 26170544)
38. A.E. Fleckenstein, R.R. Metzger, J.W. Gibb, and G.R. Hanson A rapid and reversible change in dopamine transporters induced by methamphetamine Eur J Pharmacol 323 1997 R9 R10 (Pubitemid 27152287)
39. A.E. Fleckenstein, T.J. Volz, E.L. Riddle, J.W. Gibb, and G.R. Hanson New insights into the mechanism of action of amphetamines Annu Rev Pharmacol Toxicol 47 2007 681 698
40. G. Fukami, K. Hashimoto, K. Koike, N. Okamura, E. Shimizu, and M. Iyo Effect of antioxidant N-acetyl-l-cysteine on behavioral changes and neurotoxicity in rats after administration of methamphetamine Brain Res 1016 2004 90 95 (Pubitemid 38834276)
41. G. Gerdeman, and D.M. Lovinger CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum J Neurophysiol 85 2001 468 471 (Pubitemid 32062158)
42. M.R. Gluck, L.Y. Moy, E. Jayatilleke, K.A. Hogan, L. Manzino, and P.K. Sonsalla Parallel increases in lipid and protein oxidative markers in several mouse brain regions after methamphetamine treatment J Neurochem 79 2001 152 160 (Pubitemid 32946652)
43. J. Goncalves, T. Martins, R. Ferreira, N. Milhazes, F. Borges, and C.F. Ribeiro et al. Methamphetamine-induced early increase of IL-6 and TNF-alpha mRNA expression in the mouse brain Ann N Y Acad Sci 1139 2008 103 111
44. B. Gorg, N. Qvartskhava, P. Voss, T. Grune, D. Haussinger, and F. Schliess Reversible inhibition of mammalian glutamine synthetase by tyrosine nitration FEBS Lett 581 2007 84 90 (Pubitemid 44960284)
45. D.G. Graham Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones Mol Pharmacol 14 1978 633 643 (Pubitemid 8402469)
46. N. Granado, S. Ares-Santos, E. O'Shea, C. Vicario-Abejon, M.I. Colado, and R. Moratalla Selective vulnerability in striosomes and in the nigrostriatal dopaminergic pathway after methamphetamine administration: early loss of TH in striosomes after methamphetamine Neurotox Res 18 2010 48 58
47. N. Granado, S. Ares-Santos, and R. Moratalla Methamphetamine and Parkinson's disease Park Dis 2013 2013 308052
48. G.A. Gudelsky Effect of ascorbate and cysteine on the 3,4-methylenedioxymethamphetamine-induced depletion of brain serotonin J Neural Transm 103 1996 1397 1404 (Pubitemid 27023175)
49. T.R. Guilarte, M.K. Nihei, J.L. McGlothan, and A.S. Howard Methamphetamine-induced deficits of brain monoaminergic neuronal markers: distal axotomy or neuronal plasticity Neuroscience 122 2003 499 513 (Pubitemid 37410176)
50. M. Hadamitzky, A. Markou, and R. Kuczenski Extended access to methamphetamine self-administration affects sensorimotor gating in rats Behav Brain Res 217 2011 386 390
51. G.C. Hadlock, K.M. Webb, L.M. McFadden, P.W. Chu, J.D. Ellis, and S.C. Allen et al. 4-Methylmethcathinone (mephedrone): neuropharmacological effects of a designer stimulant of abuse J Pharmacol Exp Ther 339 2011 530 536
52. L.E. Halpin, and B.K. Yamamoto Peripheral ammonia as a mediator of methamphetamine neurotoxicity J Neurosci 32 2012 13155 13163
53. J.P. Hansen, E.L. Riddle, V. Sandoval, J.M. Brown, J.W. Gibb, and G.R. Hanson et al. Methylenedioxymethamphetamine decreases plasmalemmal and vesicular dopamine transport: mechanisms and implications for neurotoxicity J Pharmacol Exp Ther 300 2002 1093 1100 (Pubitemid 34165017)
54. D. Harris, and S.L. Batki Stimulant psychosis: symptom profile and acute clinical course Am J Addict 9 2000 28 37 (Pubitemid 30155031)
55. H.M. Haughey, J.M. Brown, D.G. Wilkins, G.R. Hanson, and A.E. Fleckenstein Differential effects of methamphetamine on Na(+)/Cl(-)-dependent transporters Brain Res 863 2000 59 65 (Pubitemid 30201584)
56. M. Herkenham, A.B. Lynn, M.R. Johnson, L.S. Melvin, B.R. de Costa, and K.C. Rice Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study J Neurosci 11 1991 563 583
57. D.F. Hermens, D.I. Lubman, P.B. Ward, S.L. Naismith, and I.B. Hickie Amphetamine psychosis: a model for studying the onset and course of psychosis Med J Aust 190 2009 S22 S25
58. R. Hong, E. Matsuyama, and K. Nur Cardiomyopathy associated with the smoking of crystal methamphetamine JAMA 265 1991 1152 1154
59. A.J. Hotchkiss, and J.W. Gibb Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain J Pharmacol Exp Ther 214 1980 257 262 (Pubitemid 10049032)
60. Y.H. Huang, S.J. Tsai, T.W. Su, and C.B. Sim Effects of repeated high-dose methamphetamine on local cerebral glucose utilization in rats Neuropsychopharmacology 21 1999 427 434
61. C.C. Huang, S.W. Lo, and K.S. Hsu Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons J Physiol 532 2001 731 748
62. H.C. Hung, and E.H. Lee The mesolimbic dopaminergic pathway is more resistant than the nigrostriatal dopaminergic pathway to MPTP and MPP + toxicity: role of BDNF gene expression Brain Res Mol Brain Res 41 1996 14 26
63. S.Z. Imam, F. Islam, Y. Itzhak, W. Slikker Jr., and S.F. Ali Prevention of dopaminergic neurotoxicity by targeting nitric oxide and peroxynitrite: implications for the prevention of methamphetamine-induced neurotoxic damage Ann N Y Acad Sci 914 2000 157 171
64. E.J. Ishac, L. Jiang, K.D. Lake, K. Varga, M.E. Abood, and G. Kunos Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB1 receptors on peripheral sympathetic nerves Br J Pharmacol 118 1996 2023 2028 (Pubitemid 26292572)
65. D. James, R.D. Adams, R. Spears, G. Cooper, D.J. Lupton, and J.P. Thompson et al. Clinical characteristics of mephedrone toxicity reported to the U.K. National Poisons Information Service Emerg Med J 28 2011 686 689
66. S. Jayanthi, B. Ladenheim, and J.L. Cadet Methamphetamine-induced changes in antioxidant enzymes and lipid peroxidation in copper/zinc-superoxide dismutase transgenic mice Ann N Y Acad Sci 844 1998 92 102 (Pubitemid 28367798)
67. S. Jayanthi, B. Ladenheim, A.M. Andrews, and J.L. Cadet Overexpression of human copper/zinc superoxide dismutase in transgenic mice attenuates oxidative stress caused by methylenedioxymethamphetamine (Ecstasy) Neuroscience 91 1999 1379 1387 (Pubitemid 29234266)
68. S. Jayanthi, X. Deng, M. Bordelon, M.T. McCoy, and J.L. Cadet Methamphetamine causes differential regulation of pro-death and anti-death Bcl-2 genes in the mouse neocortex FASEB J 15 2001 1745 1752 (Pubitemid 32730222)
69. S. Jayanthi, X. Deng, B. Ladenheim, M.T. McCoy, A. Cluster, and N.S. Cai et al. Calcineurin/NFAT-induced up-regulation of the Fas ligand/Fas death pathway is involved in methamphetamine-induced neuronal apoptosis Proc Natl Acad Sci U S A 102 2005 868 873 (Pubitemid 40282757)
70. W. Jeng, A. Ramkissoon, T. Parman, and P.G. Wells Prostaglandin H synthase-catalyzed bioactivation of amphetamines to free radical intermediates that cause CNS regional DNA oxidation and nerve terminal degeneration FASEB J 20 2006 638 650 (Pubitemid 44933308)
71. C.E. Johanson, K.A. Frey, L.H. Lundahl, P. Keenan, N. Lockhart, and J. Roll et al. Cognitive function and nigrostriatal markers in abstinent methamphetamine abusers Psychopharmacology (Berl) 185 2006 327 338
72. A.L. Jones, D.R. Jarvie, G. McDermid, and A.T. Proudfoot Hepatocellular damage following amphetamine intoxication J Toxicol Clin Toxicol 32 1994 435 444 (Pubitemid 24269368)
73. T. Kadota, and K. Kadota Neurotoxic morphological changes induced in the medial prefrontal cortex of rats behaviorally sensitized to methamphetamine Arch Histol Cytol 67 2004 241 251 (Pubitemid 39612257)
74. Y. Kamijo, K. Soma, M. Nishida, A. Namera, and T. Ohwada Acute liver failure following intravenous methamphetamine Vet Hum Toxicol 44 2002 216 217 (Pubitemid 34778794)
75. D.P. Kasick, C.A. McKnight, and E. Klisovic "Bath salt" ingestion leading to severe intoxication delirium: two cases and a brief review of the emergence of mephedrone use Am J Drug Alcohol Abuse 38 2012 176 180
76. I. Katona, B. Sperlagh, A. Sik, A. Kafalvi, E.S. Vizi, and K. Mackie et al. Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons J Neurosci 19 1999 4544 4558 (Pubitemid 29241104)
77. J. Kleijn, J. Wiskerke, T.I. Cremers, A.N. Schoffelmeer, B.H. Westerink, and T. Pattij Effects of amphetamine on dopamine release in the rat nucleus accumbens shell region depend on cannabinoid CB1 receptor activation Neurochem Int 60 2012 791 798
78. E. Kosenko, Y. Kaminsky, E. Grau, M.D. Minana, S. Grisolia, and V. Felipo Nitroarginine, an inhibitor of nitric oxide synthetase, attenuates ammonia toxicity and ammonia-induced alterations in brain metabolism Neurochem Res 20 1995 451 456
79. E. Kosenko, M. Llansola, C. Montoliu, P. Monfort, R. Rodrigo, and M. Hernandez-Viadel et al. Glutamine synthetase activity and glutamine content in brain: modulation by NMDA receptors and nitric oxide Neurochem Int 43 2003 493 499 (Pubitemid 36561304)
80. I.N. Krasnova, Z. Justinova, B. Ladenheim, S. Jayanthi, M.T. McCoy, and C. Barnes et al. Methamphetamine self-administration is associated with persistent biochemical alterations in striatal and cortical dopaminergic terminals in the rat PLoS One 5 2010 e8790
81. J.H. Krystal, L.H. Price, C. Opsahl, G.A. Ricaurte, and G.R. Heninger Chronic 3,4-methylenedioxymethamphetamine (MDMA) use: effects on mood and neuropsychological function? Am J Drug Alcohol Abuse 18 1992 331 341
82. R. Kuczenski, I.P. Everall, L. Crews, A. Adame, I. Grant, and E. Masliah Escalating dose-multiple binge methamphetamine exposure results in degeneration of the neocortex and limbic system in the rat Exp Neurol 207 2007 42 51 (Pubitemid 47332481)
83. D.M. Kuhn, and T.J. Geddes Peroxynitrite inactivates tryptophan hydroxylase via sulfhydryl oxidation. Coincident nitration of enzyme tyrosyl residues has minimal impact on catalytic activity J Biol Chem 274 1999 29726 29732
84. D.M. Kuhn, C.W. Aretha, and T.J. Geddes Peroxynitrite inactivation of tyrosine hydroxylase: mediation by sulfhydryl oxidation, not tyrosine nitration J Neurosci 19 1999 10289 10294 (Pubitemid 30228036)
85. D.M. Kuhn, D.M. Francescutti-Verbeem, and D.M. Thomas Dopamine quinones activate microglia and induce a neurotoxic gene expression profile: relationship to methamphetamine-induced nerve ending damage Ann N Y Acad Sci 1074 2006 31 41 (Pubitemid 44532808)
86. M.J. LaVoie, and T.G. Hastings Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: evidence against a role for extracellular dopamine J Neurosci 19 1999 1484 1491 (Pubitemid 29088929)
87. G.C. Loewinger, M.V. Beckert, H.A. Tejeda, and J.F. Cheer Methamphetamine-induced dopamine terminal deficits in the nucleus accumbens are exacerbated by reward-associated cues and attenuated by CB1 receptor antagonism Neuropharmacology 62 2012 2192 2201
88. H. Lorez Fluorescence histochemistry indicates damage of striatal dopamine nerve terminals in rats after multiple doses of methamphetamine Life Sci 28 1981 911 916 (Pubitemid 11099949)
89. D.T. Malone, and D.A. Taylor Modulation by fluoxetine of striatal dopamine release following Delta9-tetrahydrocannabinol: a microdialysis study in conscious rats Br J Pharmacol 128 1999 21 26 (Pubitemid 29425263)
90. K. Maresz, E.J. Carrier, E.D. Ponomarev, C.J. Hillard, and B.N. Dittel Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli J Neurochem 95 2005 437 445 (Pubitemid 41457512)
91. K.A. Mark, J.J. Soghomonian, and B.K. Yamamoto High-dose methamphetamine acutely activates the striatonigral pathway to increase striatal glutamate and mediate long-term dopamine toxicity J Neurosci 24 2004 11449 11456 (Pubitemid 39658280)
92. L.A. Matsuda, S.J. Lolait, M.J. Brownstein, A.C. Young, and T.I. Bonner Structure of a cannabinoid receptor and functional expression of the cloned cDNA Nature 346 1990 561 564
93. U.D. McCann, D.F. Wong, F. Yokoi, V. Villemagne, R.F. Dannals, and G.A. Ricaurte Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428 J Neurosci 18 1998 8417 8422 (Pubitemid 28465016)
94. U.D. McCann, M. Mertl, V. Eligulashvili, and G.A. Ricaurte Cognitive performance in (+/-) 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users: a controlled study Psychopharmacology 143 1999 417 425 (Pubitemid 29222488)
95. U.D. McCann, Z. Szabo, E. Seckin, P. Rosenblatt, W.B. Mathews, and H.T. Ravert et al. Quantitative PET studies of the serotonin transporter in MDMA users and controls using [11C]McN5652 and [11C]DASB Neuropsychopharmacology 30 2005 1741 1750 (Pubitemid 43086031)
96. L.M. McFadden, G.C. Hadlock, S.C. Allen, P.L. Vieira-Brock, K.A. Stout, and J.D. Ellis et al. Methamphetamine self-administration causes persistent striatal dopaminergic alterations and mitigates the deficits caused by a subsequent methamphetamine exposure J Pharmacol Exp Ther 340 2012 295 303
97. L.M. McFadden, M.M. Hunt, P.L. Vieira-Brock, J. Muehle, S.M. Nielsen, and S.C. Allen et al. Prior methamphetamine self-administration attenuates serotonergic deficits induced by subsequent high-dose methamphetamine administrations Drug Alcohol Depend 126 2012 87 94
98. C. McGregor, M. Srisurapanont, J. Jittiwutikarn, S. Laobhripatr, T. Wongtan, and J.M. White The nature, time course and severity of methamphetamine withdrawal Addiction 100 2005 1320 1329 (Pubitemid 41248073)
99. R. McKetin, J. McLaren, D.I. Lubman, and L. Hides The prevalence of psychotic symptoms among methamphetamine users Addiction 101 2006 1473 1478 (Pubitemid 44337772)
100. C.M. Milroy, J.C. Clark, and A.R. Forrest Pathology of deaths associated with "ecstasy" and "eve" misuse J Clin Pathol 49 1996 149 153
101. H. Mizoguchi, S. Arai, H. Koike, D. Ibi, H. Kamei, and T. Nabeshima et al. Therapeutic potential of nicotine for methamphetamine-induced impairment of sensorimotor gating: involvement of pallidotegmental neurons Psychopharmacology (Berl) 207 2009 235 243
102. K.H. Moon, V.V. Upreti, L.R. Yu, I.J. Lee, X. Ye, and N.D. Eddington et al. Mechanism of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)-mediated mitochondrial dysfunction in rat liver Proteomics 8 2008 3906 3918
103. M.J. Morgan Recreational use of "ecstasy" (MDMA) is associated with elevated impulsivity Neuropsychopharmacology 19 1998 252 264 (Pubitemid 28491335)
104. S. Munro, K.L. Thomas, and M. Abu-Shaar Molecular characterization of a peripheral receptor for cannabinoids Nature 365 1993 61 65 (Pubitemid 23305569)
105. J.F. Nash, and B.K. Yamamoto Methamphetamine neurotoxicity and striatal glutamate release: comparison to 3,4-methylenedioxymethamphetamine Brain Res 581 1992 237 243
106. H. Neumann Control of glial immune function by neurons Glia 36 2001 191 199 (Pubitemid 33055907)
107. J.M. Ng Cheong Ton, G.A. Gerhardt, M. Friedemann, A.M. Etgen, G.M. Rose, and N.S. Sharpless et al. The effects of delta 9-tetrahydrocannabinol on potassium-evoked release of dopamine in the rat caudate nucleus: an in vivo electrochemical and in vivo microdialysis study Brain Res 451 1988 59 68
108. D.G. Nicholls Mitochondrial dysfunction and glutamate excitotoxicity studied in primary neuronal cultures Curr Mol Med 4 2004 149 177 (Pubitemid 38425912)
109. F. Nifosi, A. Martinuzzi, T. Toffanin, R. Costanzo, A. Vestri, and M. Battaglia et al. Hippocampal remodelling after MDMA neurotoxicity: a single case study World J Biol Psychiatry 10 2009 961 968
110. W.L. Nixdorf, K.B. Burrows, G.A. Gudelsky, and B.K. Yamamoto Enhancement of MDMA neurotoxicity by the energy inhibitor malonate J. Neurochemistry 77 2001 647 654 (Pubitemid 32298759)
111. E. O'Hearn, G. Battaglia, E.B. De Souza, M.J. Kuhar, and M.E. Molliver Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity J Neurosci 8 1988 2788 2803
112. L. Orio, E. O'Shea, V. Sanchez, J.M. Pradillo, I. Escobedo, and J. Camarero et al. 3,4-Methylenedioxymethamphetamine increases interleukin-1beta levels and activates microglia in rat brain: studies on the relationship with acute hyperthermia and 5-HT depletion J Neurochem 89 2004 1445 1453 (Pubitemid 38802666)
113. E. O'Shea, V. Sanchez, L. Orio, I. Escobedo, A.R. Green, and M.I. Colado 3,4-Methylenedioxymethamphetamine increases pro-interleukin-1beta production and caspase-1 protease activity in frontal cortex, but not in hypothalamus, of Dark Agouti rats: role of interleukin-1beta in neurotoxicity Neuroscience 135 2005 1095 1105 (Pubitemid 41416673)
114. A.C. Parrott, A. Lees, N.J. Garnham, M. Jones, and K. Wesnes Cognitive performance in recreational users of MDMA of 'ecstasy': evidence for memory deficits J Psychopharmacol 12 1998 79 83 (Pubitemid 28143002)
115. A. Patel, T. Moreland, F. Haq, F. Siddiqui, M. Mikul, and H. Qadir et al. Persistent psychosis after a single ingestion of "ecstasy" (MDMA) Prim Care Companion CNS Disord 13 2011
116. M.P. Paulus, S.F. Tapert, and M.A. Schuckit Neural activation patterns of methamphetamine-dependent subjects during decision making predict relapse Arch Gen Psychiatry 62 2005 761 768 (Pubitemid 41002757)
117. F.E. Pontieri, A.M. Crane, L.S. Seiden, M.S. Kleven, and L.J. Porrino Metabolic mapping of the effects of intravenous methamphetamine administration in freely moving rats Psychopharmacology 102 1990 175 182 (Pubitemid 20264656)
118. M.N. Potash, K.A. Gordon, and K.L. Conrad Persistent psychosis and medical complications after a single ingestion of MDMA "ecstasy": a case report and review of the literature Psychiatry 6 2009 40 44
119. J. Pourahmad, M.R. Eskandari, M. Nosrati, F. Kobarfard, and A.R. Khajeamiri Involvement of mitochondrial/lysosomal toxic cross-talk in ecstasy induced liver toxicity under hyperthermic condition Eur J Pharmacol 643 2010 162 169
120. D. Pubill, A.M. Canudas, M. Pallas, A. Camins, J. Camarasa, and E. Escubedo Different glial response to methamphetamine- and methylenedioxymethamphetamine-induced neurotoxicity Naunyn Schmiedebergs Arch Pharmacol 367 2003 490 499 (Pubitemid 36718300)
121. R.A. Puffenbarger, A.C. Boothe, and G.A. Cabral Cannabinoids inhibit LPS-inducible cytokine mRNA expression in rat microglial cells Glia 29 2000 58 69 (Pubitemid 30031134)
122. L. Quate, D.E. McBean, I.M. Ritchie, H.J. Olverman, and P.A. Kelly Acute methylenedioxymethamphetamine administration: effects on local cerebral blood flow and glucose utilisation in the Dark Agouti rat Psychopharmacology 173 2004 287 295 (Pubitemid 38703802)
123. B.G. Ramirez, C. Blazquez, T. Gomez del Pulgar, M. Guzman, and M.L. de Ceballos Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation J Neurosci 25 2005 1904 1913 (Pubitemid 40289395)
124. G.A. Ricaurte, C.R. Schuster, and L.S. Seiden Long-term effects of repeated methylamphetamine administration on dopamine and serotonin neurons in the rat brain: a regional study Brain Res 193 1980 153 163 (Pubitemid 10120970)
125. G.A. Ricaurte, R.W. Guillery, L.S. Seiden, C.R. Schuster, and R.Y. Moore Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain Brain Res 235 1982 93 103 (Pubitemid 12188130)
126. G. Ricaurte, G. Bryan, L. Strauss, L. Seiden, and C. Schuster Hallucinogenic amphetamine selectively destroys brain serotonin nerve terminals Science 229 1985 986 988 (Pubitemid 16248493)
127. E.L. Riddle, M.K. Topham, J.W. Haycock, G.R. Hanson, and A.E. Fleckenstein Differential trafficking of the vesicular monoamine transporter-2 by methamphetamine and cocaine Eur J Pharmacol 449 2002 71 74
128. R.D. Rogers, B.J. Everitt, A. Baldacchino, A.J. Blackshaw, R. Swainson, and K. Wynne et al. Dissociable deficits in the decision-making cognition of chronic amphetamine abusers, opiate abusers, patients with focal damage to prefrontal cortex, and tryptophan-depleted normal volunteers: evidence for monoaminergic mechanisms Neuropsychopharmacology 20 1999 322 339 (Pubitemid 29099763)
129. R.B. Rothman, and M.H. Baumann Monoamine transporters and psychostimulant drugs Eur J Pharmacol 479 2003 23 40 (Pubitemid 37377873)
130. G. Rudnick, and S.C. Wall The molecular mechanism of "ecstasy" [3,4-methylenedioxy-methamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release Proc Natl Acad Sci U S A 89 1992 1817 1821
131. V. Sanchez, J. Camarero, E. O'Shea, A.R. Green, and M.I. Colado Differential effect of dietary selenium on the long-term neurotoxicity induced by MDMA in mice and rats Neuropharmacology 44 2003 449 461 (Pubitemid 36293977)
132. V. Sava, O. Reunova, A. Velasquez, S. Song, and J. Sanchez-Ramos Neuroanatomical mapping of DNA repair and antioxidative responses in mouse brain: effects of a single dose of MPTP Neurotoxicology 27 2006 1080 1093 (Pubitemid 44848373)
133. C.J. Schmidt, J.K. Ritter, P.K. Sonsalla, G.R. Hanson, and J.W. Gibb Role of dopamine in the neurotoxic effects of methamphetamine J Pharmacol Exp Ther 233 1985 539 544 (Pubitemid 15019746)
134. L.S. Seiden, D.L. Commins, G. Vosmer, K. Axt, and G. Marek Neurotoxicity in dopamine and 5-hydroxytryptamine terminal fields: a regional analysis in nigrostriatal and mesolimbic projections Ann N Y Acad Sci 537 1988 161 172 (Pubitemid 19029542)
135. H.S. Sharma, and E.A. Kiyatkin Rapid morphological brain abnormalities during acute methamphetamine intoxication in the rat: an experimental study using light and electron microscopy J Chem Neuroanat 37 2009 18 32
136. M. Shen, T.M. Piser, V.S. Seybold, and S.A. Thayer Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures J Neurosci 16 1996 4322 4334 (Pubitemid 26243028)
137. S.L. Simon, C.P. Domier, T. Sim, K. Richardson, R.A. Rawson, and W. Ling Cognitive performance of current methamphetamine and cocaine abusers J Addict Dis 21 2002 61 74 (Pubitemid 35203854)
138. J.L. Skibba, A. Stadnicka, and J.H. Kalbfleisch Hyperthermic liver toxicity: a role for oxidative stress J Surg Oncol 42 1989 103 112
139. D.E. Smith, and C.M. Fischer An analysis of 310 cases of acute high-dose methamphetamine toxicity in Haight-Ashbury Clin Toxicol 3 1970 117 124
140. S. Soleimani Asl, M.H. Farhadi, K. Moosavizadeh, A. Samadi Kuchak Saraei, M. Soleimani, and S.B. Jamei et al. Evaluation of Bcl-2 family gene expression in hippocampus of 3,4-methylenedioxymethamphetamine treated rats Cell J 13 2012 275 280
141. J.E. Sprague, S.L. Everman, and D.E. Nichols An integrated hypothesis for the serotonergic axonal loss induced by 3,4-methylenedioxymethamphetamine Neurotoxicology 19 1998 427 441
142. K. Sriram, D.B. Miller, and J.P. O'Callaghan Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor-alpha J Neurochem 96 2006 706 718
143. R.D. Staszewski, and B.K. Yamamoto Methamphetamine-induced spectrin proteolysis in the rat striatum J Neurochem 96 2006 1267 1276
144. S.E. Stephans, and B.K. Yamamoto Methamphetamine-induced neurotoxicity:
145. S.E. Stephans, T.S. Whittingham, A.J. Douglas, W.D. Lust, and B.K. Yamamoto Substrates of energy metabolism attenuate methamphetamine-induced neurotoxicity in striatum J Neurochem 71 1998 613 621 (Pubitemid 28480408)
146. D.M. Stone, M. Johnson, G.R. Hanson, and J.W. Gibb Role of endogenous dopamine in the central serotonergic deficits induced by 3,4- methylenedioxymethamphetamine J Pharmacol Exp Ther 247 1988 79 87
147. G. Stumm, J. Schlegel, T. Schafer, C. Wurz, H.D. Mennel, and J.C. Krieg et al. Amphetamines induce apoptosis and regulation of bcl-x splice variants in neocortical neurons FASEB J 13 1999 1065 1072 (Pubitemid 29249732)
148. D. Sulzer, and S. Rayport Amphetamine and other psychostimulants reduce pH gradients in midbrain dopaminergic neurons and chromaffin granules: a mechanism of action Neuron 5 1990 797 808
149. D. Sulzer, T.K. Chen, Y.Y. Lau, H. Kristensen, S. Rayport, and A. Ewing Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport J Neurosci 15 1995 4102 4108
150. I. Tamburini, F. Blandini, M. Gesi, G. Frenzilli, M. Nigro, and M. Giusiani et al. MDMA induces caspase-3 activation in the limbic system but not in striatum Ann N Y Acad Sci 1074 2006 377 381 (Pubitemid 44532842)
151. D.M. Thomas, and D.M. Kuhn MK-801 and dextromethorphan block microglial activation and protect against methamphetamine-induced neurotoxicity Brain Res 1050 2005 190 198 (Pubitemid 40922733)
152. D.M. Thomas, P.D. Walker, J.A. Benjamins, T.J. Geddes, and D.M. Kuhn Methamphetamine neurotoxicity in dopamine nerve endings of the striatum is associated with microglial activation J Pharmacol Exp Ther 311 2004 1 7 (Pubitemid 39287777)
153. E. Torres, M.D. Gutierrez-Lopez, E. Borcel, I. Peraile, A. Mayado, and E. O'Shea et al. Evidence that MDMA ('ecstasy') increases cannabinoid CB2 receptor expression in microglial cells: role in the neuroinflammatory response in rat brain J Neurochem 113 2010 67 78
154. K. Tsou, S. Brown, M.C. Sanudo-Pena, K. Mackie, and J.M. Walker Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system Neuroscience 83 1998 393 411 (Pubitemid 28062631)
155. E. Turillazzi, I. Riezzo, M. Neri, S. Bello, and V. Fineschi MDMA toxicity and pathological consequences: a review about experimental data and autopsy findings Curr Pharm Biotechnol 11 2010 500 509
156. N.D. Volkow, L. Chang, G.J. Wang, J.S. Fowler, D. Franceschi, and M. Sedler et al. Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence J Neurosci 21 2001 9414 9418 (Pubitemid 33096884)
157. N.D. Volkow, L. Chang, G.J. Wang, J.S. Fowler, M. Leonido-Yee, and D. Franceschi et al. Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers Am J Psychiatry 158 2001 377 382 (Pubitemid 32205193)
158. G.C. Wagner, G.A. Ricaurte, L.S. Seiden, C.R. Schuster, R.J. Miller, and J. Westley Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine Brain Res 181 1980 151 160 (Pubitemid 10159505)
159. A.M. Wang, J.N. Suojanen, V.M. Colucci, C.L. Rumbaugh, and N.K. Hollenberg Cocaine- and methamphetamine-induced acute cerebral vasospasm: an angiographic study in rabbits AJNR Am J Neuroradiol 11 1990 1141 1146 (Pubitemid 20359019)
160. X. Wang, S.P. Zhu, W.H. Kuang, J. Li, X. Sun, and M.S. Huang et al. Neuron apoptosis induced by 3,4-methylenedioxy methamphetamine and expression of apoptosis-related factors in rat brain Sichuan Da Xue Xue Bao Yi Xue Ban 40 2009 1000 1002 [1037]
161. G.J. Wang, L. Smith, N.D. Volkow, F. Telang, J. Logan, and D. Tomasi et al. Decreased dopamine activity predicts relapse in methamphetamine abusers Mol Psychiatry 17 2012 918 925
162. M. Wijetunga, T. Seto, J. Lindsay, and I. Schatz Crystal methamphetamine-associated cardiomyopathy: tip of the iceberg? J Toxicol Clin Toxicol 41 2003 981 986 (Pubitemid 38018490)
163. W.L. Woolverton, G.A. Ricaurte, L.S. Forno, and L.S. Seiden Long-term effects of chronic methamphetamine administration in rhesus monkeys Brain Res 486 1989 73 78 (Pubitemid 19102851)
164. B.K. Yamamoto, and W. Zhu The effects of methamphetamine on the production of free radicals and oxidative stress J Pharmacol Exp Ther 287 1998 107 114 (Pubitemid 29140192)
165. Y. Yiangou, P. Facer, P. Durrenberger, I.P. Chessell, A. Naylor, and C. Bountra et al. COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord BMC Neurol 6 2006 12
166. J.P. Zhu, W. Xu, and J.A. Angulo Methamphetamine-induced cell death: selective vulnerability in neuronal subpopulations of the striatum in mice Neuroscience 140 2006 607 622
167. J.P. Zhu, W. Xu, N. Angulo, and J.A. Angulo Methamphetamine-induced striatal apoptosis in the mouse brain: comparison of a binge to an acute bolus drug administration Neurotoxicology 27 2006 131 136 (Pubitemid 41745016)
168. J.Y. Zou, and F.T. Crews TNF alpha potentiates glutamate neurotoxicity by inhibiting glutamate uptake in organotypic brain slice cultures: neuroprotection by NF kappa B inhibition Brain Res 1034 2005 11 24 (Pubitemid 40248516)